Therapeutic Effect of Lecithinized Superoxide Dismutase against Colitis
Open Access
- 16 October 2008
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 328 (1), 152-164
- https://doi.org/10.1124/jpet.108.144451
Abstract
Ulcerative colitis (UC) involves intestinal mucosal damage induced by reactive oxygen species (ROS), in particular, superoxide anion. Superoxide dismutase (SOD) catalyzes dismutation of superoxide anion to hydrogen peroxide, which is subsequently detoxified by catalase. Lecithinized SOD (PC-SOD) is a new modified form of SOD that has overcome previous clinical limitations of SOD. In this study, we examined the action of PC-SOD using an animal model of UC, dextran sulfate sodium (DSS)-induced colitis. DSS-induced colitis was ameliorated by daily intravenous administration of PC-SOD. Unmodified SOD produced a similar effect but only at more than 30 times the concentration of PC-SOD. In vivo electron spin resonance analysis confirmed that the increase in the colonic level of ROS associated with development of colitis was suppressed by PC-SOD administration. The dose-response profile of PC-SOD was bell-shaped, but simultaneous administration of catalase restored the ameliorative effect at high doses of PC-SOD. Accumulation of hydrogen peroxide was observed with the administration of high doses of PC-SOD, an effect that was suppressed by the simultaneous administration of catalase. We also found that either a weekly intravenous administration or daily oral administration of PC-SOD conferred protection. These results suggest that PC-SOD achieves its ameliorative effect against colitis through decreasing the colonic level of ROS and that its ineffectiveness at higher doses is because of the accumulation of hydrogen peroxide. Furthermore, we consider that intermittent or oral administration of PC-SOD can be applied clinically to improve the quality of life of UC patients.This publication has 37 references indexed in Scilit:
- Applicability of new spin trap agent, 2-diphenylphosphinoyl-2-methyl-3,4-dihydro-2H-pyrrole N-oxide, in biological systemBiochemical and Biophysical Research Communications, 2008
- Pharmacokinetics of PC-SOD, a Lecithinized Recombinant Superoxide Dismutase, After Single- and Multiple-Dose Administration to Healthy Japanese and Caucasian VolunteersThe Journal of Clinical Pharmacology, 2008
- The pharmacokinetics and effects of a long‐acting preparation of superoxide dismutase (PC‐SOD) in manBritish Journal of Clinical Pharmacology, 2007
- Lecithinized Superoxide Dismutase Improves Outcomes and Attenuates Focal Cerebral Ischemic Injury via Antiapoptotic Mechanisms in RatsStroke, 2007
- Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and MalignanciesJama-Journal Of The American Medical Association, 2006
- Emerging biotherapies for inflammatory bowel diseaseEmerging Drugs, 2003
- In vivo lipid‐derived free radical formation by NADPH oxidase in acute lung injury induced by lipopolysaccharide: a model for ARDSThe FASEB Journal, 2002
- Preventive Effects of Lecithinized Superoxide Dismutase and Methylprednisolone on Spinal Cord Injury in Rats: Transcriptional Regulation of Inflammatory and Neurotrophic GenesJournal of Neurotrauma, 2001
- Superoxide Scavenging Activity of Erythromycin–Iron ComplexBiochemical and Biophysical Research Communications, 1997
- Role of reactive oxygen metabolites in experimental colitis.Gut, 1990